The Food and Drug Administration has revealed that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow multiple safety protocols.
The FDA visited a Global Pharma Healthcare facility in India for an inspection in mid-February and found dozens of issues ranging from dirty equipment and clothing to missing safeguards and procedures.
The inspection came two-and-a-half weeks after the company voluntarily recalled the EzriCare artificial tears product because of possible contamination.
When the recall was issued, there were already 55 reports of adverse events, including eye infections, permanent loss of vision, and at least one death from a bloodstream infection.
You don’t have to be an Olympic-level athlete to wear On’s shoes or apparel, but the company will use the 2024 games to continue growing its footprint.
Companies are making money, the economy is cooling down, and a rate cut or two possible by the fall? It might be time to break out the cautious optimism.
Fed Chair Jerome Powell reported that rates would likely remain elevated due to sticky inflation. Zillow breaks down how this could impact the housing market.
Amanda Chin, SVP of Marketing for the Golden State Warriors, stops by Cheddar to debut Valkyries name and logo and talks why women sports is good for business.
